Imipramine Hydrochloride Rosemont Pharmaceuticals

Imipramine Hydrochloride, the active ingredient in Imipramine Hydrochloride Rosemont Pharmaceuticals, is a tricyclic antidepressant presented as an oral tablet for oral use. It treats major depressive disorder, panic disorder, nocturnal enuresis, and certain chronic pain conditions in adult patients. It is commonly prescribed by psychiatrists and pain specialists.

GNH USA supplies Imipramine Hydrochloride Rosemont Pharmaceuticals as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable, quality‑assured medicines to meet clinical demand across Europe, Asia, Africa and the Americas.

Imipramine acts on the central nervous system to modify mood and pain pathways. It is indicated for several recognized conditions: - Major depressive disorder: alleviates depressive symptoms and improves mood. - Panic disorder: reduces frequency and severity of panic attacks. - Nocturnal enuresis: decreases nighttime urinary episodes in children. - Chronic pain: helps manage neuropathic and other persistent pain conditions.

Imipramine may cause a range of adverse reactions, varying in frequency and severity.

Common Side Effects: - Dry mouth: reduced salivary flow causing discomfort. - Constipation: slowed gastrointestinal motility. - Drowsiness: increased sedation, especially at treatment initiation. - Blurred vision: transient visual disturbances.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm requiring monitoring. - Seizures: heightened risk in predisposed individuals. - Severe hypotension: marked drop in blood pressure, potentially causing dizziness or fainting.

Before initiating therapy, clinicians should consider several safety measures. - Cardiac assessment: evaluate history of heart disease or conduction abnormalities. - Blood pressure monitoring: watch for orthostatic changes. - Suicidal ideation: assess mental health status regularly. - Elderly patients: start at lower doses due to increased sensitivity. - Discontinuation: taper gradually to avoid withdrawal symptoms. - Store at ambient temperature: keep in the original pack, protect from moisture.

Imipramine can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Monoamine oxidase inhibitors: risk of serotonin syndrome. - Selective serotonin reuptake inhibitors: increased serotonergic toxicity. - Other tricyclic antidepressants: additive cardiotoxic effects.

Moderate Interactions (Monitor Closely): - Antihistamines: enhanced sedation. - CYP2D6 inhibitors: may raise imipramine plasma levels. - Diuretics: potential for orthostatic hypotension.